CTOs on the Move

Boston MicroFluidics

www.bostonmicrofluidics.com

 
Boston Microfluidics (BMF) is dedicated to connecting people to their health by increasing access to diagnostic testing for all people. Our technology is a unique combination of elegant sample processing solutions with an intuitive user interface. We strive to streamline current testing systems with devices that perform complex sample processing steps without the need for trained professionals or specialized laboratory equipment. We also seek to simplify diagnostic tests so that they can be used efficiently at the point of care, or even be available for direct sale to consumers. Above all, BMF works to help provide patients with ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Boston MicroFluidics raised $17.5M on 08/27/2019

Similar Companies

North Central Connecticut EMS Council Inc

North Central Connecticut EMS Council Inc is a Hartford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Delmont Labs

Delmont Labs is a Swarthmore, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Creative Community Living

Creative Community Living is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Winfield, KS. To find more information about Creative Community Living, please visit www.cclccl.org

Pine Trails Park

Parkland is a diverse community of 30,000, and the City provides a variety of services for these citizens. Learn more about what Parkland has to offer you and your family! Parkland is a tranquil city nestled in a serene, wooded environment in Northwest...

Repertoire

Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.